Buradasınız

Anasayfa » Content

PRÎMER HİPERTANSİYON: RENAL VASKÜLER DİSFONKSÎYON

PRIMARY HYPERTENSION: RENAL VASCULAR DYSFUNCTION

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2003

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Renal failure due to primary hypertension (HT) can be declined with precautions at early stages. In our study, glomerulo-tubular vascular function markers of 245 HT patients without end-organ damage have a mean age of 48±9 years, systolic blood pressure (SBP) 159±14, and diastolic blood pressure (DBP) 101+8 mmHg, were compared to 141 healthy individuals with a mean age of 46+9 and SBP, DBP 119+8, 78±5 mmHg respectively. According to control group, familial HT history, SBP, DBP (P<0.00001), body mass index (BMI, p<0.0001) and glucose (FBS, P<0.005) uric acid (UA, P<0.001) in serum, and daily urinary excretion ofprotein (UP, P<0.001), albumin (UAE), N-aceytl-D-glucosaminidase (NAG, p<0.00001), fi-2-microglobulin (film, P<0.005) were found to be elavated in HT group. A significant decline in serum Na+ was observed (P<0.05) in 110 patients whom SBP / DBP remained > 140 and/or 90 mmHg after a dietary salt restriction for one week. In BMI-II group (25-30 kg/m2) UA, UAE (P<0.001), NAG, film (P<0.005) levels were found to be higher than in BMI-I (<25 kg/m2) group. Positive correlations were found between hypertensive retinopathy (%59-HR) to patient's age, HT duration, SBP, DBP UA; and between smoking to UA, hemoglobin (Hb) and between FBG to BMI, serum Na+ in HT group. When compared to healtys', increased FBG (P<0.05) sCr (P<0.005) UA, UAE (P<0.0005), in hypertensive males and elevated Hb, fi2m (P<0.005), BMI, UP (P<0.0005), UA, UAE, NAG (P<0.00005) in hypertensive females were found. Our findings suggest that renal vascular dysfunctions were occurred at early stages in HT, males have tendency to systemic, females to renal vascular damages are increased with obesity, smoking, salt.
Abstract (Original Language): 
Primer Hipertansiyon (HT)'a bağlı böbrek yetmezliklerinin gelişimi erken evrede alınan önlemlerle azaltılabilmektedir. Çalışmamızda, yaş ortalaması 48+9 yıl, sistolik/diyastolik kan basıncı (SKB/DKB) 159+14 / 101+8 mmtig olan, hedef organ hasarsız 245 HTlu ile yaş ortalaması 46+9 yıl, SKB/ DKB 119+8/ 78±5 mnıHg olan 141 sağlıklı bireyin, glomerülo-tubiiler vasküler fonksiyon göstergeleri karşılaştırıldı. Sağlıklı gruba göre, ailede HT öyküsü, SKB, DKB (p<0.00001), vücut kitle indeksi (VKİ, p<0.0001) ile serumda; glukoz (AKŞ, p<0.005), ürik asit (ÜA) ve günlük idrarla atılan protein (UP, P<0.001), albumin (UAE), N-Asetil-D-glukosaminidaz (NAG, P<0.00001), b-2-mikroglobülin (b2m, P<0.005) değerleri HT grubunda yüksek bulundu. Bir hafta diyet tuzunu azaltmaları önerilen 137 hastadan KB >140 ve/ ya 90 mmHg de kalan 110 ununda, serum Na* unda anlamlı düşüş gözlendi (P<0.05). VKİ-II. derece (25-30 kg/m2) olan hastaların ÜA, UAE(P<0.001), NAG, b2m ıP<0.005) değerleri VKİ-I. derece (< 25 kg/m2) olanlardan yüksek bulundu. Hipertansif retinopati (% 59) ile hasta yaşı ve HT süresi, SKB, DKB, ÜA; sigara ile ÜA, hemoglobin (Hb); AKŞ ile VKİ, Na+ arasında pozitif ilişki saptandı. Sağlıklı gruba göre, hipertansif erkeklerin AKŞ (P<0.05), sKr (P<0.005), UAE P<0.0005) ve hipertansif kadınların Hb, b2m P<0.005), VKİ, UP (P<0.0005), UA, UAE, NAG p<0.00005) değerleri artmış bulundu. Çalışmamızda, renal vasküler fonksiyonların HT'nun erken evresinde " jzulduğunu, erkeklerin sistemik vasküler, kadınların renal vasküler bozulmaya daha yatkın olduğunu, obezite, sigara, tuzla vasküler bozulmanın arttığım gözledik.
FULL TEXT (PDF): 
PDF icon pdf_tndt_444.pdf

REFERENCES

References: 

1. Luke RG. Hypertensive nephrosclerosis: Pathogenesis and prevalence. Nephrol Dial Transplant 1999; 14: 2271-78
2. Türk Nefroloji Derneği Registry 2000: Istanbul 2001; 13-28
3.
Tadde
i S, Vrdis A, Ghiadoni L, Salvetti A. The role of endothelium in human hypertension. Curr Opin
Nephrol Hypertens 1998,7: 203-91
4. Runge MS, Huber AR. Mechanisms of lesion development. In: Braunwald E (ed). Atlas of heart Diseases, Volume X. Singapore, Imago Productions (FE) ltd. 1996:3.1-3.15
5. Montalescot G, Philippe F, Ankri A, et al. Early increase of von Willebrand Factor predicts adverse outcome in unstable coronary artery disease.
Circulation 1998; 98: 294-8
6. Massy ZA, Keane W. Pathogenesis of atherosclerosis. Semin Nephrol 1996; 16: 12-20
7. Ruilope LM. Renal implications of arterial hypertension. Curr Opin Nephrol Hypertens 1997; 6: 152-6
8. Subcommittee G: 1999 World Health Organization-International society of hypertension guidelines for the management of hypertension. Journal of
Hypertension 1999;17:151-183
9. Smith HT. Hypertension and the kidney. Am Journal
Hypertens 1993;6:1195-1225
10. Metcalf P, Baker J, Scott A, Wild C, Scragg R,
Dryson E: Albuminuria in people at least 40 years old: effect of obesity, hypertension and
hyperlipidemia. ClinChem 1992;38:1802-1808
11. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG. Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an
older population. Kidney Int 2000; 57: 2072-79
12. Cushman WC, Cutler JA, Hanna E, et al. Prevention and treatment hypertension study (PATHS): Effects of an alcohol treatment program on blood pressure.
Arch Intern Med 1998; 158: 1197-207
13. Kurokawa K. Kidney, salt, and hypertension: How and why. Kidney Int 1996; 49 (suppl 55): S46-S41
14. Whelton PK, Klag MJ, Perneger TV. Prevention of blood pressure-related kidney failure: an epidemiological perfective. Semin Dial 1993; 6: 84¬86
15. Johnson RJ, Kivlingh SD, Kim J-G, Suga S, Fogo AB. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 1999; 33: 225-34
16. Burnier M, Brunner HR. Is hyperuricemia a predictor of cardiovascular disease. Curr Opin Nephrol
Hypertens 1999; 8: 167-72
17. Nityanand S, Pande I, Virender K et al. Platelets in essential hypertension. Thrombosis Research 1993; 72:447-54
18. Reaven GM, Lithell. H, Landsberg L. Hypertension and associated metabolic abnormalities. The role of insulin resistance .and the sympathoadrenal system. New Eng J Med 1996; 334: 374-81
19. Jones CA, McQuillan GM, Kusek JW, et al. Serum
creatinine levels in the US population: Third national health and nutrition examination survey. Am J
Kidney Dis 1998;32:992-99
20. Schillachi G, Reboldi G, Verdecchia P. High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch
Inten Med 2001; 161:886-91
21. Mimran A, Ribstein J, DuCailar G. Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension ?
Hypertension 1994; 23: 1018-21
22. Abraham PA, Mascioli SR, Launer CA, et al. Urinary
albumin and N-acetyl-B-D-glucosaminidase excretions in mild hypertension. Am J Hypertens 1994;7:965-74
23. Scarpelli PT, Chegai E, Castigli E, Livi R, Cagnoni M, Cappelli G. Renal handling of albumin and Beta-2-MicrogIobulin in human hypertension. Nephron 1985;40:122-3
24. Sakharova OV, Taal MW, Brenner BM.
Pathogenesis of diabetic nephropathy: focus on transforming growth factor- B and connective tissue growth factor. Curr Opin Nephrol Hypertens 2001; 10: 727-38
25. Luft FC. Microalbuminuria and essential hypertension: renal and cardiovascular implications.
Curr Opin Nephrol Hypertens 1997; 6: 553-7
26. Schmieder RE, Rockstroh JK, Munch HG et al.
Elevated serum activity of N-acetyl-B-glucosaminidase in essential hypertension: Diagnostic value and reversal to normal values after antihypertensive therapy. Am J Kidney Dis 1991; 18: 638-48
27. Cirillo M, Laurenzi M, Trevisan M et al. Hematocrit, blood pressure, and hypertension. Hypertension 1992;20:319-26
28. Agirbasli M, Radhakrishnamurthy B, Jiang X et al. Urinary N-acetyl-b-glucosaminidase changes in relation to age sex, race, and diastolic and systolic blood pressure in a young adult biracial population.
Am J Hypertens 1996;9:157-161
29. Brenner BM, Anderson S. The interrelation-ships among filtration surface area, blood pressure, and chronic renal disease. J Cardiovasc Pharmacol 1992; 19 (suppl 6): 1-7
30. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J
Kidney Dis 1994; 23: 171-75
31. Hall JE. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 1994; 23: 381¬94

Thank you for copying data from http://www.arastirmax.com